A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Inhibrx Biosciences, Inc
Nanobiotix
Turnstone Biologics, Corp.
University of Giessen
Inhibrx Biosciences, Inc
SCG Cell Therapy Pte. Ltd.
Celldex Therapeutics
HRYZ Biotech Co.
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Institut de Cancérologie de Lorraine
University of Wisconsin, Madison
Boston Medical Center
Stanford University
Butler Hospital
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Chinese University of Hong Kong
University of Kansas Medical Center
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)